Evaluating the efficacy of Memantine on improving Cognitive Functions in Epileptic Patients receiving Anti-Epileptic Drugs: A double blind placebo controlled clinical study

Trial Profile

Evaluating the efficacy of Memantine on improving Cognitive Functions in Epileptic Patients receiving Anti-Epileptic Drugs: A double blind placebo controlled clinical study

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Memantine (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Oct 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
    • 26 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top